Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00091572
Status:
COMPLETED
Last Update Posted:
2017-06-06
First Post:
2004-09-10
Brief Title:
Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma Study P03267
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC